CeleCor Therapeutics, a biotech company advancing prehospital heart attack treatments, partnered with Wondros to create an investor-focused digital presence for their lead drug, zalunfiban. The goal was to communicate the drug’s clinical significance through a science-driven website tailored to pharma professionals, cardiologists, and strategic partners. The project included branding, UX strategy, investor content development, and full website design—delivered through an agile approach to navigate delays and maintain momentum. The result was a professional, mobile-responsive site featuring downloadable materials, clear medical storytelling, and a CMS built for scalability—positioning CeleCor for future growth, partnerships, and investment opportunities.